Advances in Public Health / 2022 / Article / Tab 2 / Research Article
Measles-Rubella Positivity Rate and Associated Factors in Pre-Mass and Post-Mass Vaccination Periods: Analysis of Uganda Routine Surveillance Laboratory Data Table 2 Factors associated with the measles outcome among laboratory-examined cases before and after the 2019 measles-rubella mass vaccination campaign.
Variable Precampaign season (n = 1373) Postcampaign season (n = 324) Positive Negative χ 2 valuePositive Negative χ 2 valueSex Male 297 (41.77) 414 (58.23) 0.010 0.934 68 (38.42) 109 (61.58) 0.030 0.853 Female 278 (41.99) 384 (58.01) 55 (37.41) 92 (62.59) Age UANE 82 (71.30) 33 (28.70) 58.94 0.001 32 (64.00) 18 (36.00) 51.91 <0.001 RICE 421 (37.39) 705 (62.61) 51 (23.94) 162 (76.06) OANE 72 (54.55) 60 (45.45) 40 (65.57) 21 (34.43) Place of residence Urban 1 (100) 0 (0.00) 0.419 0 (0.00) 2 (100) 0.528 Rural 574 (41.84) 798 (58.16) 123 (38.20) 199 (61.80) Vaccination status Not vaccinated 336 (49.48) 343 (50.52) 60.48 <0.001 65 (48.87) 68 (51.13) 16.90 0.001 1 dose 152 (30.46) 347 (69.54) 26 (33.77) 51 (66.23) 2+ doses 16 (24.24) 50 (75.76) 12 (19.05) 51 (80.95) Unknown 71 (55.04) 58 (44.96) 20 (39.22) 31 (60.78) Vitamin A doses 1 dose 134 (36.71) 231 (63.29) 7.06 0.029 28 (41.18) 40 (58.82) 0.72 0.697 2+ doses 223 (45.79) 264 (54.21) 43 (35.25) 78 (64.75) Unknown 218 (41.84) 303 (58.16) 52 (38.81) 82 (61.19) Specimen condition Good 575 (42.06) 792 (57.94) 0.078 122 (37.77) 201 (62.23) Bad 0 (0.00) 5 (100) 0 (0.00) 0 (0.00)
Fisher’s exact test;
not applicable.